Fabienne Jouen

Rouen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Daratumumab as a therapeutic option for rituximab-recalcitrant pemphigus.

Daratumumab as a therapeutic option for rituximab-recalcitrant pemphigus.

Journal: The Journal of investigative dermatology

Published: May 18, 2026

French national protocol for diagnosis and management of pemphigoid gestationis.

French national protocol for diagnosis and management of pemphigoid gestationis.

Journal: Annales de dermatologie et de venereologie

Published: November 05, 2025

Cohort study of 23 patients with seropositive immune-mediated necrotizing myopathy.

Cohort study of 23 patients with seropositive immune-mediated necrotizing myopathy.

Journal: La Revue de medecine interne

Published: September 09, 2025

Incidence of P200 pemphigoid: A nationwide study.

Incidence of P200 pemphigoid: A nationwide study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 11, 2025

Comparative analysis of clinical profile, therapeutic management, and clinical prognosis of patients with seropositive or seronegative rheumatoid arthritis following the introduction of a first targeted therapy in a real-life setting.

Comparative analysis of clinical profile, therapeutic management, and clinical prognosis of patients with seropositive or seronegative rheumatoid arthritis following the introduction of a first targeted therapy in a real-life setting.

Journal: Clinical rheumatology

Published: December 04, 2024

Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositis.

Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositis.

Journal: Rheumatology (Oxford, England)

Published: November 22, 2024

Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceus.

Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceus.

Journal: The British journal of dermatology

Published: March 07, 2024

TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients.

TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients.

Journal: Rheumatology (Oxford, England)

Published: January 10, 2024

Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies.

Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies.

Journal: Antibodies (Basel, Switzerland)

Published: December 23, 2023

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.

Journal: The British journal of dermatology

Published: May 17, 2023

Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases.

Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases.

Journal: Frontiers in immunology

Published: December 30, 2022

Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.

Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 10, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026